Details for New Drug Application (NDA): 210459
✉ Email this page to a colleague
The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
Summary for 210459
Tradename: | CLARITHROMYCIN |
Applicant: | Alembic |
Ingredient: | clarithromycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210459
Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 210459
Suppliers and Packaging for NDA: 210459
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 210459 | ANDA | Alembic Pharmaceuticals Limited | 46708-344 | 46708-344-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-344-30) |
CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 210459 | ANDA | Alembic Pharmaceuticals Limited | 46708-344 | 46708-344-60 | 60 TABLET, FILM COATED in 1 BOTTLE (46708-344-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Jan 31, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Jan 31, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription